HKSE - Delayed Quote • HKD
Brii Biosciences Limited (2137.HK)
At close: April 26 at 4:08 PM GMT+8
Major Holders
Breakdown | |
---|---|
5.51% | % of Shares Held by All Insider |
36.95% | % of Shares Held by Institutions |
39.10% | % of Float Held by Institutions |
18 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
SPDR Portfolio Emerging Markets ETF | 261k | Feb 29, 2024 | 0.04% | 302,759 |
Avantis Emerging Markets Equity Fund | 109k | Mar 31, 2024 | 0.01% | 126,439 |
Avantis Emerging Markets Equity ETF | 109k | Feb 29, 2024 | 0.01% | 126,439 |
Avantis Emerging Markets Small Cap Equity ETF | 2.5k | Feb 29, 2024 | 0.00% | 2,899 |
SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 15.5k | Feb 29, 2024 | 0.00% | 17,979 |
Related Tickers
1873.HK Viva Biotech Holdings
0.560
0.00%
2197.HK Clover Biopharmaceuticals, Ltd.
0.360
+9.09%
1877.HK Shanghai Junshi Biosciences Co., Ltd.
10.740
+4.88%
9939.HK Kintor Pharmaceutical Limited
0.960
+2.13%
6160.HK BeiGene, Ltd.
91.950
+2.17%
2179.HK Jiangsu Recbio Technology Co., Ltd.
9.130
0.00%
AVXT AVAX Technologies, Inc.
0.0001
0.00%
002252.SZ Shanghai RAAS Blood Products Co., Ltd.
7.19
-0.96%
1477.HK Ocumension Therapeutics
6.470
+7.83%
41X.F Ardelyx, Inc.
5.83
-3.60%